Clinical Trial Update: Assessing the Efficacy of Maxidex® and Patanol® for the Treatment of Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports results from a study evaluating the efficacy of Maxidex and Patanol for allergic conjunctivitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• Maxidex (dexamethasone 0.1%)
• Patanol (olopatadine hydrochloride)

Snippet

Sponsor: Alcon Research | Conditions: Allergic Conjunctivitis | Phase 4 | Status: COMPLETED | Results posted: 2013-03-06